Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson’s Disease

Abstract

Increasing the function of residual dopaminergic neurons in the nigra of PD patients is an important area of research as it may eventually compensate the loss. Although tyrosine hydroxylase (TH) is the rate-limiting enzyme in the dopamine (DA) biosynthesis pathway, there are no effective drugs/molecules to upregulate TH and increase the production of DA in nigral dopaminergic neurons. This study underlines the importance of aspirin in stimulating the expression of TH and increasing the level of DA in dopaminergic neurons. At low doses, aspirin increased the expression of TH and the production of DA in mouse MN9D dopaminergic neuronal cells. Accordingly, oral administration of aspirin increased the expression of TH in the nigra and upregulated the level of DA in striatum of normal C57/BL6 mice and aged A53T α-syn transgenic mice. Oral aspirin also improved locomotor activities of normal mice and A53T transgenic mice. While investigating mechanisms, we found the presence of cAMP response element (CRE) in the promoter of TH gene and the rapid induction of cAMP response element binding (CREB) activation by aspirin in dopaminergic neuronal cells. Aspirin treatment also increased the level of phospho-CREB in the nigra of C57/BL6 mice. The abrogation of aspirin-induced expression of TH by siRNA knockdown of CREB and the recruitment of CREB to the TH gene promoter by aspirin suggest that aspirin stimulates the transcription of TH in dopaminergic neurons via CREB. These results highlight a new property of aspirin in stimulating the TH-DA pathway, which may be beneficial in PD patients.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

References

  1. Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71:1635–1642

    Article  CAS  PubMed  Google Scholar 

  2. Belgacem YH, Borodinsky LN (2017) CREB at the crossroads of activity-dependent regulation of nervous system development and function. Adv Exp Med Biol 1015:19–39

    Article  PubMed  Google Scholar 

  3. Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, Nemachek C, Green SR, Przedborski S, Gendelman HE (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 101:9435–9440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O'Neil A, Davey CG, Sanna L, Maes M (2013) Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med 11:74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Brahmachari S, Pahan K (2007) Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis. J Immunol 179:275–283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Brahmachari S, Jana A, Pahan K (2009) Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 183:5917–5927

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chandra G, Kundu M, Rangasamy SB, Dasarathy S, Ghosh S, Watson R, Pahan K (2017) Increase in Mitochondrial Biogenesis in Neuronal Cells by RNS60, a Physically-Modified Saline, via Phosphatidylinositol 3-Kinase-Mediated Upregulation of PGC1alpha. J NeuroImmune Pharmacol

  8. Chandra S, Jana M, Pahan K (2018) Aspirin induces Lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of Alzheimer's disease via PPARalpha. J Neurosci 38:6682–6699

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Corbett GT, Roy A, Pahan K (2012) Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense. J Immunol 189:1002–1013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dai Y, Ge J (2012) Clinical use of aspirin in treatment and prevention of cardiovascular disease. Thrombosis 2012:245037

    Article  CAS  PubMed  Google Scholar 

  11. Dasgupta S, Jana M, Liu X, Pahan K (2003) Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells. J Biol Chem 278:22424–22431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889–909

    Article  CAS  PubMed  Google Scholar 

  13. Gagne JJ, Power MC (2010) Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 74:995–1002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ghosh A, Pahan K (2012) Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders. J Biol Chem 287:27189–27203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 104:18754–18759

    Article  PubMed  PubMed Central  Google Scholar 

  16. Jana A, Modi KK, Roy A, Anderson JA, van Breemen RB, Pahan K (2013) Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders. J NeuroImmune Pharmacol 8:739–755

    Article  PubMed  PubMed Central  Google Scholar 

  17. Jana M, Ghosh S, Pahan K (2018) Upregulation of myelin gene expression by a physically-modified saline via phosphatidylinositol 3-kinase-mediated activation of CREB: implications for multiple sclerosis. Neurochem Res 43:407–419

    Article  CAS  PubMed  Google Scholar 

  18. Kern S, Skoog I, Ostling S, Kern J, Borjesson-Hanson A (2012) Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women. BMJ Open 2:e001288

    Article  PubMed  PubMed Central  Google Scholar 

  19. Khasnavis S, Pahan K (2012) Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J NeuroImmune Pharmacol 7:424–435

    Article  PubMed  Google Scholar 

  20. Khasnavis S, Pahan K (2014) Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease. J NeuroImmune Pharmacol 9:569–581

    Article  PubMed  PubMed Central  Google Scholar 

  21. Khasnavis S, Jana A, Roy A, Mazumder M, Bhushan B, Wood T, Ghosh S, Watson R, Pahan K (2012) Suppression of nuclear factor-kappaB activation and inflammation in microglia by physically modified saline. J Biol Chem 287:29529–29542

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Khasnavis S, Roy A, Ghosh S, Watson R, Pahan K (2014) Protection of dopaminergic neurons in a mouse model of Parkinson's disease by a physically-modified saline containing charge-stabilized nanobubbles. J NeuroImmune Pharmacol 9:218–232

    Article  PubMed  Google Scholar 

  23. Kopp E, Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956–959

    Article  CAS  PubMed  Google Scholar 

  24. Lang AE, Lozano AM (1998) Parkinson's disease. First of two parts. N Engl J Med 339:1044–1053

    Article  CAS  PubMed  Google Scholar 

  25. Marsden CD (1990) Parkinson's disease. Lancet 335:948–952

    Article  CAS  PubMed  Google Scholar 

  26. Modi KK, Sendtner M, Pahan K (2013) Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis. J Biol Chem 288:18533–18545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Modi KK, Rangasamy SB, Dasarathi S, Roy A, Pahan K (2016) Cinnamon converts poor learning mice to good learners: implications for memory improvement. J NeuroImmune Pharmacol 11:693–707

    Article  PubMed  PubMed Central  Google Scholar 

  28. Mondal S, Roy A, Pahan K (2009) Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis. J Immunol 182:5013–5023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mondal S, Roy A, Jana A, Ghosh S, Kordower JH, Pahan K (2012) Testing NF-kappaB-based therapy in hemiparkinsonian monkeys. J NeuroImmune Pharmacol 7:544–556

    Article  PubMed  PubMed Central  Google Scholar 

  30. Moyad MA (2001) An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II. Semin Urol Oncol 19:306–316

    CAS  PubMed  Google Scholar 

  31. Nilsson SE, Johansson B, Takkinen S, Berg S, Zarit S, McClearn G, Melander A (2003) Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years. Eur J Clin Pharmacol 59:313–319

    Article  CAS  PubMed  Google Scholar 

  32. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123–144

    Article  CAS  PubMed  Google Scholar 

  33. Patel D, Roy A, Kundu M, Jana M, Luan CH, Gonzalez FJ, Pahan K (2018) Aspirin binds to PPARalpha to stimulate hippocampal plasticity and protect memory. Proc Natl Acad Sci U S A 115:E7408–E7417

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR (2004) Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 56:532–539

    Article  PubMed  Google Scholar 

  35. Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379:1591–1601

    Article  CAS  PubMed  Google Scholar 

  36. Roy A, Pahan K (2013) Myelin basic protein-primed T helper 2 cells suppress microglial activation via AlphaVBeta3 integrin: implications for multiple sclerosis. J Clin Cell Immunol 7:158

    PubMed  PubMed Central  Google Scholar 

  37. Roy A, Pahan K (2015) PPARalpha signaling in the hippocampus: crosstalk between fat and memory. J NeuroImmune Pharmacol 10:30–34

    Article  PubMed  PubMed Central  Google Scholar 

  38. Roy A, Fung YK, Liu X, Pahan K (2006) Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 281:14971–14980

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Roy A, Jana M, Kundu M, Corbett GT, Rangaswamy SB, Mishra RK, Luan CH, Gonzalez FJ, Pahan K (2015) HMG-CoA Reductase inhibitors bind to PPARalpha to Upregulate Neurotrophin expression in the brain and improve memory in mice. Cell Metab 22:253–265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Saura CA, Cardinaux JR (2017) Emerging roles of CREB-regulated transcription Coactivators in brain physiology and pathology. Trends Neurosci 40:720–733

    Article  CAS  PubMed  Google Scholar 

  41. Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232–235

    Article  CAS  Google Scholar 

  43. Vane JR, Botting RM (2003) The mechanism of action of aspirin. Thromb Res 110:255–258

    Article  CAS  PubMed  Google Scholar 

  44. Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson's disease. Nat Med 10(Suppl):S58–S62

    Article  CAS  PubMed  Google Scholar 

  45. WHO (2017) 20th Model List of Essential Medicine. In: http://www.who.int/medicines/publications/essentialmedicines/20th_EML2017_FINAL_amendedAug2017.pdf?ua=1, pp 2,25,36,50

  46. Zhang F, Lu YF, Wu Q, Liu J, Shi JS (2012) Resveratrol promotes neurotrophic factor release from astroglia. Exp Biol Med (Maywood) 237:943–948

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by merit awards from Department of Veteran Affairs (I01BX002174 and I01BX003033) and a grant (NS083054) from NIH.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kalipada Pahan.

Ethics declarations

Conflict of Interests

None.

Electronic supplementary material

ESM 1

(PDF 1105 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rangasamy, S.B., Dasarathi, S., Pahan, P. et al. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson’s Disease. J Neuroimmune Pharmacol 14, 173–187 (2019). https://doi.org/10.1007/s11481-018-9808-3

Download citation

Keywords

  • Aspirin
  • Tyrosine hydroxylase
  • Dopamine
  • CREB
  • Substantia nigra pars compacta
  • Striatum